Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT06430541
- Phase
- PHASE1
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Psilocybin — DRUGA tryptamine that produces its behavioral effects primarily by acting as post-synaptic agonists at serotonin 5-HT2A and 5-HT2c receptors.
Study Details
The goal of this clinical trial is to test whether psilocybin along with therapy in women with early breast cancer and ovarian cancer in remission can improve their fear of recurrence. The main question\[s\] it aims to answer \[is/are\]: Does psilocybin assisted therapy improve fear of cancer recurrence? Does psilocybin assisted therapy improve anxiety, depression, and quality of life? Participants will complete a series of survey measures, participate in preparatory therapy. After prep therapy is complete, they will receive a moderately high dose of psilocybin in a monitored and supportive environment. After the dosing day, they will complete 4 sessions of integrative therapy and complete survey measures.
Key Dates
- Start date
- Nov 21, 2024
- Status verified
- Jul 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Psilocybin Assisted Psychotherapy25mg cGMP Psilocybin in combination with manualized therapy
Primary Outcome Measure
Change in Fear of Cancer Recurrence Inventory [ Time Frame: 1-week, 4-weeks, 8-weeks* (primary outcome time point), 12-weeks, and 24-weeks. ]
Central Contacts
- Mary Mancuso303-724-5729
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Outpatient CTRC | Aurora | Colorado | 80045 | Stacy Fischer, MD (PRINCIPAL_INVESTIGATOR) |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | Stacy Fischer, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Aurora, CO
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After LumpectomyPHASE3 · Recruiting · Rocky Mountain Cancer Centers · Aurora, Colorado
- The Immune System's Response to Young Women's Breast CancerRecruiting · University of Colorado, Denver · Aurora, Colorado
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado